ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "T cell activation"

  • 2018 American Transplant Congress

    TLR2 with TCR Signaling Mobilizes Treg Lymphatic Migration

    W. Piao, Y. Xiong, L. Li, V. Saxena, J. Bromberg.

    UMB, MD.

    Background: Regulatory T cells (Treg) express high levels of lymphotoxin (LT) and bind the LT receptor (LTβR) on lymphatic endothelial cells (LEC). This receptor-ligand interaction…
  • 2018 American Transplant Congress

    Hematopoietic Cell Kinase (Hck) Regulates Effector and Regulatory T Cell (Treg) Function

    S. Farouk,1 C. Wei,1 B. Das,2 P. Cravedi,1 B. Murphy.1

    1Department of Medicine, Division of Nephrology, Icahn School of Medicine at Mt. Sinai, New York, NY; 2Department of Pharmacological Sciences, Icahn School of Medicine at Mt. Sinai, New York, NY.

    Background: We found that upregulation of Hck mRNA expression, an Src family tyrosine kinase, in surveillance graft biopsies of kidney transplant patients associates with an…
  • 2018 American Transplant Congress

    Preventing of Rejection of Vascularized Composite Allografts by Targeting T Cell Metabolism

    B. Oh,1 C. Cheng,2 G. Furtmüller,1 K. Donovan,1 W. Lee,1 J. Powell,2 G. Brandacher.1

    1Plastic and Reconstructive Surgery, Johns Hopkins SOM, Baltimore; 2Oncology, Johns Hopkins SOM, Baltimore.

    [Background] Upon antigen recognition and co-stimulation, T lymphocytes upregulate the metabolic machinery necessary to proliferate and sustain effector function. This metabolic reprogramming in T cells…
  • 2018 American Transplant Congress

    Central Role of Mef2 Transcription Factors in Regulation of Foxp3 Expression and Treg Function

    A. Samanta,1 L. Wang,1 R. Han,1 W. Hancock.1,2

    1CHOP, Philadelphia; 2UPenn, Philadelphia.

    Foxp3+ Tregs express 4 class IIa Hdac enzymes (Hdac4, 5, 7 & 9) with little or no catalytic activity and yet when deleted, at least…
  • 2018 American Transplant Congress

    Shikonin Inhibits Th17 Development through Repressing STAT3 Activation

    H. Fang,1 R. Zhang,1 F. Liang,1 Q. Chen,2 J. Ochando,3 Y. Ding,1 J. Xu.1

    1Department of Immunology, Capital Medical University, Beijing, China; 2Department of Thoracic Surgery, Chaoyang Hospital, Beijing, China; 3Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.

    Background: Th17-mediated inflammatory responses are detrimental for allograft acceptance and long-term survival after transplantation. Shikonin is a naphthoquinone pigment isolated from a traditional medicinal herb…
  • 2018 American Transplant Congress

    Rapamycin Impairs Human Endothelial Cell Alloimmunogenicity Independent of PD-1/PD-1 Ligand Inhibitory Signaling

    Q. Gao, V. Bendersky, A. Kirk, H. Xu.

    Department of Surgery, Duke University Medical Center, Durham, NC.

    Rapamycin prevents costimulation blockade (CoB)-resistant rejection in mice and primates, and early human data suggests a similar salutary effect. We have hypothesized that one mechanism…
  • 2018 American Transplant Congress

    Targeting Calcium Release-Activated Calcium (CRAC) Channel in Non-Human Primate Kidney Transplantation

    J. Kwun,1 B. Ezekian,1 M. Manook,1 J. Park,1 J. Yoon,1 J. Sloan-Lancaster,2 C. Fortier,3 P. Rao,4 S. Knechtle.1

    1Surgery, Duke University, Durham, NC; 2Eli Lilly and Company, Indianapolis, IN, Canada; 3PRCL Research Inc, Montreal, QC, Canada; 4Synta Pharmaceuticals Inc., Lexington, MA.

    [Background] Long-term administration of calcineurin inhibitors (CNIs) successfully controls rejection of transplanted organs. However, the chronic use of these drugs causes organ damage often resulting…
  • 2018 American Transplant Congress

    Activity Nanosensors for Early and Noninvasive Detection of Acute Organ Transplant Rejection

    Q. Mac,1 D. Mathews,2 J. Kahla,1 C. Stoffers,1 O. Delmas,1 B. Holt,1 A. Adams,2 G. Kwong.1

    1Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA; 2Department of Surgery, Emory University School of Medicine, Atlanta, GA.

    Purpose: We engineered activity nanosensors that sense anti-allograft T cell activity in vivo to noninvasively detect the onset of acute cellular rejection from urine.Methods: Granzyme…
  • 2018 American Transplant Congress

    Belatacept-Refractory CD8+CD28–CD38hi Effector/Memory T Cells Are Targeted by mTOR Inhibition Leading to a Preferential Loss of CD40L

    C. Castro Rojas,1 A. Godarova,1 A. Rike Shields,2 R. Alloway,2 M. Jordan,3 E. Woodle,2 D. Hildeman.1

    1Division of Immunobiology, Cincinnati Children's Hospital, University of Cincinnati College of Medicine, Cincinnati, OH; 2Division of Transplantation, University of Cincinnati College of Medicine, Cincinnati, OH; 3Division of Bone Marrow Transplant and Immune Deficiency, Cincinnati Children's Research Foundation, Cincinnati, OH.

    Calcineurin inhibitors (CNIs) and corticosteroids (CSS) have substantial untoward side effects, most notably nephrotoxicity. Consequently, the FDA approved belatacept for maintenance immunosuppression. We recently completed…
  • 2018 American Transplant Congress

    Recipient IFNAR1 Signaling Supports Costimulation Independent Rejection by Promoting T Cell Activation

    D. Mathews, A. Ghosh, Y. Dong, K. Polireddy, A. Stephenson, C. Breeden, Y. Liu, A. Adams.

    Department of Surgery, Emory University, Atlanta, GA.

    Costimulation blockade (CoB) is a promising strategy for more targeted/less toxic transplant immunosuppression which has led to the first improvement in long-term outcomes for transplant…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 20
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences